Adverse events154

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 154

Type	Event	Organ system	Group	Affected	At risk
other	Alkaline phosphatase	Metabolism and nutrition disorders	All Patients Enrolled and Treated With TKI 258	23	40
other	Allergy/Immunology-Other (Specify)	Immune system disorders	All Patients Enrolled and Treated With TKI 258	1	40
other	Alopecia	Endocrine disorders	All Patients Enrolled and Treated With TKI 258	1	40
other	ALT, SGPT (serum glutamic pyruvic transaminase)	Hepatobiliary disorders	All Patients Enrolled and Treated With TKI 258	10	40
other	Amylase	Metabolism and nutrition disorders	All Patients Enrolled and Treated With TKI 258	4	40
other	Anemia	Metabolism and nutrition disorders	All Patients Enrolled and Treated With TKI 258	8	40
other	Anorexia	Metabolism and nutrition disorders	All Patients Enrolled and Treated With TKI 258	22	40
other	AST, SGOT (serum glutamic oxaloacetic transaminase)	Hepatobiliary disorders	All Patients Enrolled and Treated With TKI 258	15	40
other	Ataxia (incoordination)	Nervous system disorders	All Patients Enrolled and Treated With TKI 258	1	40
other	Atrial fibrillation	Cardiac disorders	All Patients Enrolled and Treated With TKI 258	1	40
other	Atrophy, skin	Skin and subcutaneous tissue disorders	All Patients Enrolled and Treated With TKI 258	1	40
other	Autoimmune reaction	Immune system disorders	All Patients Enrolled and Treated With TKI 258	1	40
other	Back pain	Vascular disorders	All Patients Enrolled and Treated With TKI 258	4	40
other	Bilirubin (hyperbilirubinemia)	Hepatobiliary disorders	All Patients Enrolled and Treated With TKI 258	2	40
other	Bladder spasms	Renal and urinary disorders	All Patients Enrolled and Treated With TKI 258	2	40
other	Bone pain	Vascular disorders	All Patients Enrolled and Treated With TKI 258	2	40
other	Bronchospasm, wheezing	Respiratory, thoracic and mediastinal disorders	All Patients Enrolled and Treated With TKI 258	1	40
other	Bruising (in absence of Grade 3 or 4 thrombocytopenia)	Vascular disorders	All Patients Enrolled and Treated With TKI 258	2	40
other	Calcium, serum-low (hypocalcemia)	Metabolism and nutrition disorders	All Patients Enrolled and Treated With TKI 258	9	40
other	Chest wall pain	Vascular disorders	All Patients Enrolled and Treated With TKI 258	2	40

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00831792/events

API reference For AI assistants

Adverse events154

Sources 3

Read this list from software.